This website is being migrated. In case you don't find the information you are looking for, the old website can be found here. Thank you for reporting any anomalies to communication@ill.eu.

News

AdobeStock_812599620.jpeg
Feb. 4, 2025 Neutrons for the quantum technologies of the future: breakthrough results on layered perovskites
Multiferroic materials will be at the heart of new solutions for data storage, data transmission, and quantum computers. Understanding the origin of such properties at fundamental level is key for developing applications, and neutron scattering techniques are a powerful tool. The story of so-called layered perovskites and the breakthrough results now published in 'Communication Materials' are a paradigmatic example. The experiments were fully conducted at the ILL, using five different instruments and taking advantage of advanced sample environment technologies.
acsodf.2025.10.issue 3.largecover 3.jpg
Jan. 30, 2025 Neutrons for antibiotics: probing cell membranes with neutron beams
Bacteria may soon replace viruses as primary pandemic concern. In our shrinking antibiotic arsenal, polymyxin B stands out as a last-resort drug capable of breaching the bacterial outer membrane – though not without side effects. A study now published brought together expertise from different neutron facilities to examine this process at the molecular scale using neutron scattering on model bacterial membranes. This work was also featured as a cover image for the journal issue.
250109_Monoclonal Antobody.jpg
Jan. 10, 2025 Never diffuse alone: understanding antibody teamwork to design tomorrow's therapeutics
Monoclonal antibodies (mAbs) are used to treat a large variety of diseases. In order to allow patients to inject these therapeutic molecules autonomously, it is crucial to understand the origin of and to control their viscosity. An international team of researchers used an interdisciplinary approach to understand how molecular interactions and motions influence the viscosity of different mAbs. The study has now been published in the journal Molecular Pharmaceutics.